Fla. Federal Belviq Breast Cancer Action Survives Dismissal Motion



DOCUMENTS
  • Order


OCALA, Fla. — A Florida federal judge has refused to dismiss an action in which a woman alleges Belviq caused her breast cancer, ruling she adequately pled the weight loss drug was unreasonably dangerous because its active ingredient had a propensity to cause cancer.

However, in the Dec. 14 order, Judge Anne C. Conway of the U.S. District Court for the Middle District of Florida dismissed the plaintiff’s claim for fraudulent misrepresentation, finding plaintiff failed to adequately allege how she or her doctor’s decisions were affected by defendants’ advertisements.

Before seeking FDA approval for Belviq, defendants Eisai Inc. and Arena …

FIRM NAMES
  • Arnold & Porter Kaye Scholer LLP
  • Beasley Allen Crow Methvin Portis & Miles PC
  • Carlton Fields PA
  • Shook Hardy & Bacon LLP
  • Sidley Austin





UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

June 13, 2022 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's Webinar Series: Science in Mass Torts - What You Need to Know

February 23, 2022 - None, None
None

MORE DETAILS